ReviewCancer drug resistance (Alhambra, Calif.)2022

Aberrant calcium signalling downstream of mutations in TP53 and the PI3K/AKT pathway genes promotes disease progression and therapy resistance in triple negative breast cancer.

Alex J Eustace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.